Literature DB >> 3141040

Inhibition of the skin tumorigenicity of (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice.

W A Khan1, Z Y Wang, M Athar, D R Bickers, H Mukhtar.   

Abstract

The effect of pretreatment of skin of Sencar mice with topically applied tannic acid, quercetin and green tea polyphenols (GTP) on the skin tumor initiating activity of (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE-2) has been evaluated. The animals were pretreated with the plant phenols (tannic acid and quercetin (3000 nmol) or GTP 24 mg/mouse) for 7 days after which they received a single topical application of 200 nmol of BPDE-2 as the initiating agent. Beginning 7 days following initiation animals received twice weekly applications of 3.24 nmol of 12-O-tetradecanoyl phorbol-13-acetate (TPA). Tannic acid and GTP afforded significant protection against skin tumor induction. These inhibitory effects were verified both by prolongation of the latency period and subsequent development of tumors. Quercetin, on the other hand, afforded only moderate protection. Each phenolic compound was found to be highly effective in accelerating the disappearance of BPDE-2 from aqueous medium. Our results suggest that tannic acid and GTP have substantial potential for protecting against the skin tumorigenic response to BPDE-2 and the mechanism of inhibition may involve inactivation of the reactive carcinogenic moiety.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141040     DOI: 10.1016/0304-3835(88)90232-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Use of Polyphenolic Compounds in Dermatologic Oncology.

Authors:  Adilson Costa; Michael Yi Bonner; Jack L Arbiser
Journal:  Am J Clin Dermatol       Date:  2016-08       Impact factor: 7.403

Review 2.  Multitargeted therapy of cancer by green tea polyphenols.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

Review 3.  Response of gammadelta T Cells to plant-derived tannins.

Authors:  Jeff Holderness; Jodi F Hedges; Katie Daughenbaugh; Emily Kimmel; Jill Graff; Brett Freedman; Mark A Jutila
Journal:  Crit Rev Immunol       Date:  2008       Impact factor: 2.214

4.  Foodstuffs for preventing cancer: the preclinical and clinical development of berries.

Authors:  Gary D Stoner
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-03

5.  What Should be Taken into Consideration for a Meta-Analysis of Green Tea Consumption and Stomach Cancer Risk?

Authors:  Jeongseon Kim
Journal:  Epidemiol Health       Date:  2010-12-31

Review 6.  Polyphenols and human health: prevention of disease and mechanisms of action.

Authors:  David Vauzour; Ana Rodriguez-Mateos; Giulia Corona; Maria Jose Oruna-Concha; Jeremy P E Spencer
Journal:  Nutrients       Date:  2010-11-08       Impact factor: 5.717

Review 7.  The Role of the MAPK Signaling, Topoisomerase and Dietary Bioactives in Controlling Cancer Incidence.

Authors:  Khaled A Selim; Hend Abdelrasoul; Mohamed Aboelmagd; Ahmed M Tawila
Journal:  Diseases       Date:  2017-04-26

Review 8.  A Comprehensive Insight on the Health Benefits and Phytoconstituents of Camellia sinensis and Recent Approaches for Its Quality Control.

Authors:  Maram M Aboulwafa; Fadia S Youssef; Haidy A Gad; Ahmed E Altyar; Mohamed M Al-Azizi; Mohamed L Ashour
Journal:  Antioxidants (Basel)       Date:  2019-10-06

Review 9.  Protective mechanisms of green tea polyphenols in skin.

Authors:  Patricia OyetakinWhite; Heather Tribout; Elma Baron
Journal:  Oxid Med Cell Longev       Date:  2012-06-26       Impact factor: 6.543

10.  Green tea consumption and risk of esophageal cancer: a meta-analysis of epidemiologic studies.

Authors:  Ping Zheng; Hai-Ming Zheng; Xing-Ming Deng; Yang-de Zhang
Journal:  BMC Gastroenterol       Date:  2012-11-21       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.